Read + Share
Sfeir MM. Imipenem/Relebactam for Treatment of Carbapenem-Resistant Gram-negative Bacteria:
Where Do We Stand on in vitro Susceptibility Testing? Clin Infect Dis 2020 Jun 28. pii: 5868454. doi: 10.1093.
PMID: 32634243
|
 |
|
Sfeir MM. Imipenem/Relebactam for Treatment of Carbapenem-Resistant Gram-negative Bacteria:
Where Do We Stand on in vitro Susceptibility Testing? Clin Infect Dis 2020 Jun 28. pii: 5868454. doi: 10.1093.
PMID: 32634243
|
|
|
|